Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.43 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.43 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1882627 | 1.00 | ADRB2 (0.43) | ADRB2ADRB1ADRB3ALDH1A1EPHX1 | |
| SCHEMBL1886547 | 0.88 | ADRB2 (0.43) | ADRB2ADRB1ADRB3ALDH1A1EPHX1 | |
| SCHEMBL1893283 | 0.88 | ADRB2 (0.43) | ADRB2ADRB1ADRB3ALDH1A1EPHX1 | |
| SCHEMBL1884860 | 0.87 | ADRB2 (0.39) | ADRB2ADRB1ADRB3ALDH1A1EPHX1 | |
| SCHEMBL1889531 | 0.87 | ADRB2 (0.39) | ADRB2ADRB1ADRB3ALDH1A1EPHX1 | |
| SCHEMBL3883733 | 0.80 | ADRB2 (0.41) | ADRB2ADRB1ADRB3ALDH1A1MEN1 | |
| SCHEMBL3891100 | 0.80 | ADRB2 (0.41) | ADRB2ADRB1ADRB3ALDH1A1MEN1 | |
| SCHEMBL1883560 | 0.79 | ALDH1A1 (0.37) | ADRB2ADRB1ADRB3ALDH1A1EPHX1 | |
| SCHEMBL1884857 | 0.79 | ALDH1A1 (0.40) | ADRB2ADRB1ADRB3ALDH1A1EPHX1 | |
| SCHEMBL1888659 | 0.78 | HPGD (0.38) | ALDH1A1EPHX1MEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7935686-B2 | Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use | XENOPORT, INC. (US) | 2011-05-03 | — | — | US | disclosed |
| US-20090124582-A1 | Acyloxyalkyl Carbamate Prodrugs, Methods of Synthesis, and Use | XENOPORT, INC. (US) | 2009-05-14 | — | — | US | disclosed |
| US-7494985-B2 | Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use | XENOPORT, INC. (US) | 2009-02-24 | — | — | US | disclosed |
| US-20060111325-A1 | Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use | XENOPORT, INC. | 2006-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111325-A1 | Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use | APEH, AASDHPPT, AGPS | ADRB2 4345/4885ADRB1 3993/4885ADRB3 2931/4885 |
| US-20090124582-A1 | Acyloxyalkyl Carbamate Prodrugs, Methods of Synthesis, and Use | APEH, AASDHPPT, AGPS | ADRB2 4345/4885ADRB1 3993/4885ADRB3 2931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.